CD274 and neoplasm: Tumor infiltrating lymphocytes (TIL) are associated with better prognosis and therapeutic response, especially in TNBC15–17, and the use of immunotherapy against TNBC is based on assessment of Programmed Cell Death Protein Ligand 1 (PD-L1) in tumor biopsies18.